Health Catalyst, Inc. (HCAT) — SEC Filings
Health Catalyst, Inc. (HCAT) — 34 SEC filings. Latest: 8-K (Apr 27, 2026). Includes 13 8-K, 7 SC 13G/A, 6 10-Q.
View Health Catalyst, Inc. on SEC EDGAR
Overview
Health Catalyst, Inc. (HCAT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 27, 2026: On April 24, 2026, Health Catalyst, Inc. filed an 8-K report detailing the departure of certain officers and the appointment of new ones. The filing also includes information on compensatory arrangements for these officers and other events. Specific details regarding the individuals involved and the
Sentiment Summary
Across 34 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 29 neutral, 2 mixed. The dominant filing sentiment for Health Catalyst, Inc. is neutral.
Filing Type Overview
Health Catalyst, Inc. (HCAT) has filed 13 8-K, 6 10-Q, 2 DEF 14A, 2 10-K/A, 2 10-K, 2 SC 13G, 7 SC 13G/A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (34)
Risk Profile
Risk Assessment: Of HCAT's 25 recent filings, 1 were flagged as high-risk, 12 as medium-risk, and 12 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $236,457,000 |
| Net Income | -$86,949,000 |
| Cash Position | $40,305,000 |
| Total Assets | $587,128,000 |
| Total Debt | $153,139,000 |
Key Executives
- Dan Burton
Industry Context
Health Catalyst operates in the healthcare technology sector, providing data and analytics solutions. The industry is characterized by a strong demand for improved efficiency and patient outcomes through data utilization. However, it faces competition from established players and emerging technology firms, with a constant need for innovation and integration with diverse healthcare systems.
Top Tags
Health Catalyst (4) · filing (3) · Healthcare Technology (3) · SEC Filing (3) · governance (3) · healthcare-technology (3) · 10-Q (3) · Financial Performance (2) · executive-compensation (2) · financials (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss | $86.949M | Increased from $48.829M in 2024 for the nine months ended September 30 |
| Total Revenue | $236.457M | Increased from $226.978M in 2024 for the nine months ended September 30 |
| Cash and Cash Equivalents | $40.305M | Decreased from $249.645M at December 31, 2024 |
| Goodwill Impairment | $28.769M | Recorded for the nine months ended September 30, 2025 |
| Debt Repayment | $231.885M | Made during the nine months ended September 30, 2025 |
| Common Stock Outstanding | 70,730,884 | As of November 5, 2025 |
| Total Revenue Growth | 4.18% | Year-over-year for the nine months ended September 30 |
| Technology Revenue Growth | 9.18% | Year-over-year for the nine months ended September 30 |
| Professional Services Revenue Change | -4.39% | Year-over-year for the nine months ended September 30 |
| Cash and Cash Equivalents Change | -83.8% | From December 31, 2024, to September 30, 2025 |
| Q2 2025 Total Revenue | $76.5M | Increased 7.4% from Q2 2024's $71.2M |
| Q2 2025 Net Loss | $25.3M | Widened from Q2 2024's $22.1M |
| Q2 2025 Technology Revenue | $50.1M | Increased 8.4% from Q2 2024's $46.2M |
| YTD 2025 Total Revenue | $150.2M | Increased 6.9% from YTD 2024's $140.5M |
| YTD 2025 Net Loss | $50.1M | Widened from YTD 2024's $43.9M |
Forward-Looking Statements
- {"claim":"Other institutional investors may increase their positions in Health Catalyst, Inc. following Wellington Management Group LLP's disclosed stake.","entity":"Health Catalyst, Inc.","targetDate":"Next 6-12 months","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Health Catalyst, Inc. (HCAT)?
Health Catalyst, Inc. has 34 recent SEC filings from Jan 2024 to Apr 2026, including 13 8-K, 7 SC 13G/A, 6 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of HCAT filings?
Across 34 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 29 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Health Catalyst, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Health Catalyst, Inc. (HCAT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Health Catalyst, Inc.?
Key financial highlights from Health Catalyst, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for HCAT?
The investment thesis for HCAT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Health Catalyst, Inc.?
Key executives identified across Health Catalyst, Inc.'s filings include Dan Burton.
What are the main risk factors for Health Catalyst, Inc. stock?
Of HCAT's 25 assessed filings, 1 were flagged high-risk, 12 medium-risk, and 12 low-risk.
What are recent predictions and forward guidance from Health Catalyst, Inc.?
Recent forward-looking statements from Health Catalyst, Inc. include guidance on {"claim":"Other institutional investors may increase their positions in Health Catalyst, Inc. following Wellington Manag.